VIP and colon carcinoma: Secondly, the target specificity of [F-18]FB-[R8,15,21, L17]-VIP for colon carcinoma, a VIP receptor-positive tumor, was confirmed: high tumor absorption had been shown by 60 min, with the T/M up to 3.03.